Continued Level of Significant Insider Selling at Avexis (AVXS)

Monday, February 05, 2018 10:15 PM ET

Continued Level of Significant Insider Selling at Avexis (AVXS)

A SEC filing today revealed a notable insider sale of Avexis shares as — Dr Brian K Kaspar, Director and Officer — disposed of 15,000 shares in the company having a market value of approximately $1,771,010. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 30,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 45,000 shares and have averaged 22,500 shares per transaction over this time period.

The number of insider buy/sell trades at Avexis is above that of the 280 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 325 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Avexis insiders is lower than its peers. Within the peer group there were 33,507,513 shares purchased and 43,306,103 shares sold with company insiders disposing of 30,150 shares on average over this time period.

Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data used in composing and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.